Novartis reported CHF35.77B in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alcon AG ALC:SW 4.5B 4.37B
Amgen AMGN:US $ 32782M 97M
AstraZeneca AZN:LN 27495M 7363M
Bayer BAYN:GR € 40372M 2493M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Fresenius FRE:GR € 27289M 781M
Fresenius Medical Care FME:GR € 13116M 216M
Galapagos GLPG:NA € 27.91M 0.74M
Genmab GEN:DC DK 443M 65M
GlaxoSmithKline GSK:LN 25483M 736M
GRIFOLS GRF:SM € 7933.89M 565.82M
H. Lundbeck A/S LUN:DC 5.79B 444M
Hikma Pharmaceutical HIK:LN 932M 0
Lonza Group LONN:SW 3.65B 67M
Merck MRK:GR € 11999M 349M
Novartis NOVN:VX SF 35769M 2030M
Novartis NVS:US $ 35769M 2030M
Orion ORNBV:FH € 107.8M 0.1M
Philips PHIA:NA € 7831M 212M
Recordati REC:IM € 1147.56M 36.18M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M